| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
MedPro Systems is a Mount Arlington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
West Public Health Center is a Wheaton, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Park Forest Care Ctr is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Deep Hospitality Knowledge Mission Hill Hospitality is the KSL Capital portfolio company launched to transform select service and extended stay hotel investing. KSL is a global leader in hospitality, travel, and leisure investing. The Mission Hill team has decades of lodging experience, with a wide range of expertise across functions including operations, asset management, acquisitions, development, and capital markets. Industry Advantage Mission Hill`s approach combines the benefits of KSL`s world-leading, world-class hospitality model, with our seasoned team`s broad relationships with owners, managers, premium brands, and developers, enabling us to create the highest quality asset portfolio. Value Added Mission Hill`s value-add strategy seeks to maximize the performance of each investment while elevating the client experience. By hand-picking assets in preferred markets across the country, we avoid inherent information asymmetry and premiums associated with acquiring a portfolio. Our disciplined approach to underwriting gives us the ability to secure outsized risk adjusted returns.